Alexza Pharmaceuticals (ALXA)

4.39 -0.04  -0.90%  May 17, 8:00PM
Add to Watchlists Create an Alert

Alexza Pharmaceuticals R&D Expense Quarterly:

7.023M for Dec. 31, 2012
View Full Chart

Alexza Pharmaceuticals R&D Expense Quarterly Chart

    Alexza Pharmaceuticals Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 7.023M
    Sept. 30, 2012 4.784M
    June 30, 2012 5.01M
    March 31, 2012 5.032M
    Dec. 31, 2011 7.285M
    Sept. 30, 2011 8.051M
    June 30, 2011 6.664M
    March 31, 2011 6.262M
    Dec. 31, 2010 11.02M
    Sept. 30, 2010 6.654M
    June 30, 2010 8.29M
    March 31, 2010 7.564M
    Dec. 31, 2009 7.625M
    Sept. 30, 2009 9.183M
       
    June 30, 2009 12.00M
    March 31, 2009 10.96M
    Dec. 31, 2008 14.40M
    Sept. 30, 2008 16.77M
    June 30, 2008 15.70M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    ALXA R&D Expense Quarterly Benchmarks

    Companies
    Teva Pharmaceutical Industries 329.00M
    Forest Laboratories 240.30M
    POZEN 2.632M

    ALXA R&D Expense Quarterly Rankings

    Overall 90th percentile
    711 of 7590
    Sector 70th percentile
    192 of 651 in Healthcare
    Industry 60th percentile
    26 of 65 in Drug Manufacturers - Specialty & Generic

    ALXA R&D Expense Quarterly Range, Past 5 Years

    Minimum 4.784M Sep 2012
    Maximum 16.77M Sep 2008
    Average 8.963M